# NERx Biosciences, Inc. — Form D

NERx Biosciences, Inc. of INDIANAPOLIS, IN, a company, filed a Form D exempt-offering notice with the SEC on 2021-11-05. The offering totals $400K, of which $200K was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2021-11-05
- Form: D
- Accession: 0001764454-21-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $400K
- Amount sold: $200K
- Remaining: $200K
- Investors: 3
- Date of first sale: 2021-10-29
- Security types: equity, debt
- Revenue range: Decline to Disclose
- SEC file number: 021-420048

## Issuer

- Name: NERx Biosciences, Inc.
- CIK: 0001764454
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 212 W 10TH ST, SUITE A480, INDIANAPOLIS, IN, 46202
- Phone: 317-612-4672

## Officers, directors & promoters (7)

| Name | Role | Location |
| --- | --- | --- |
| Trent J Carrier | Director | Indianapolis, IN |
| Katherine J Pawelczak | Director | Indianapolis, IN |
| John J Turchi | Director | Indianapolis, IN |
| Katherine J Pawelczak | Executive Officer | Indianapolis, IN |
| John J Turchi | Executive Officer | Indianapolis, IN |
| Nicholas J Ball | Director | Indianapolis, IN |
| Nicholas J Ball | Executive Officer | Indianapolis, IN |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2019-01-11](https://search.stillhousedata.com/formd/0001764454-19-000001) | D | $2.5M | $850K |

## More

- [CIK 1764454 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1764454&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001764454-21-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.